Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Mutation-specific effects seen with pyrimethamine in familial ALS patients

Nov. 21, 2008

Cenomed reports on new schizophrenia and posttraumatic stress disorder candidates

Nov. 21, 2008

rhEPO shows clinical benefits for the treatment of amyotrophic lateral sclerosis

Nov. 21, 2008

Positive results emerge from phase III ALO-01 study in patients with osteoarthritis pain

Nov. 21, 2008

Accera to launch Axona for the dietary management of AD in 2009

Nov. 20, 2008

PAION successfully completes phase I sedative/anesthetic CNS-7056 study

Nov. 20, 2008

Promising procognitive effects of Abbott's new 5-HT6 receptor antagonist

Nov. 20, 2008

Potent antihyperalgesia and good safety profile with novel delta opioid receptor agonist

Nov. 20, 2008

Xytis will begin phase I trial with XY-4083 in early 2009

Nov. 20, 2008

Proteo starts phase II trial with Elafin in patients undergoing esophagectomy

Nov. 19, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...